CytomX grabs $20 mln Series C
Biotech firm CytomX has received $20 million in Series C financing. Pfizer Venture Investments led the round with participation from previous backers Third Rock Ventures, Canaan Partners and the Roche Venture Fund. In addition to the funding, Dr. Elaine Jones, executive director of venture capital at Pfizer Venture Investments, has been added to CytomX's board of directors. Her appointment becomes effective January 15, 2015.
6 January 2015•3 mins read
